NASDAQ: ATXI - Avenue Therapeutics, Inc.

Yield per half year: -32.5%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Avenue Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc., специализированная фармацевтическая компания, разрабатывает и продает продукты, предназначенные в первую очередь для использования в больницах неотложной/интенсивной терапии. Его продукт-кандидат — внутривенный трамадол, синтетический опиоид двойного действия, который проходит фазу III клинических испытаний для лечения послеоперационной острой боли. Компания была зарегистрирована в 2015 году и базируется в Нью-Йорке, штат Нью-Йорк.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2017-06-27
ISIN US05360L2051
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.avenuetx.com
Цена ао 1.81
Change price per day: 0% (1.89)
Change price per week: +2.16% (1.85)
Change price per month: +1.61% (1.86)
Change price per 3 month: -25% (2.52)
Change price per half year: -32.5% (2.8)
Change price per year: -83.37% (11.3625)
Change price per 3 year: -82.77% (10.968)
Change price per 5 year: -98.63% (137.7)
Change price per 10 year: 0% (1.89)
Change price per year to date: +9.88% (1.72)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 2.34 6
P/E 1.3 10
EV/EBITDA 0.0174 10
Total: 7

Efficiency

Title Value Grade
ROA, % -560.92 0
ROE, % -655.94 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % -115.43 0
Yield EPS, % 197.27 10
Total: 2
More

Institutions Volume Share, %
Citadel Advisors Llc 88645 0.2
Geode Capital Management, LLC 52160 0.12
Vanguard Group Inc 46293 0.1
State Street Corporation 30593 0.07
Millennium Management LLC 28605 0.06
TWO SIGMA SECURITIES, LLC 27500 0.06
HRT Financial LP 25283 0.06
Cubist Systematic Strategies, LLC 10909 0.02
Tower Research Capital LLC (TRC) 6814 0.02
Wells Fargo & Company 4624 0.01



Head Job title Payment Year of birth
Dr. Lindsay Allan Rosenwald Executive Director N/A 1955 (70 years)
Dr. Alexandra MacLean M.D. CEO & Director 413.2k 1967 (58 years)
Mr. David Jin Interim CFO, COO & Corporate Secretary N/A 1990 (35 years)
Dr. Scott A. Reines M.D., Ph.D. Interim Chief Medical Officer 69.12k 1947 (78 years)

Address: United States, New York. NY, 1140 Avenue of the America - open in Google maps, open in Yandex maps
Website: https://www.avenuetx.com